Evidence map›Paper›PMID 36152244›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Histochemical and Immunohistochemical Methods for the Identification of Proteoglycans.

David Sánchez-Porras, Juan Varas, Carlos Godoy-Guzmán, Fabiola Bermejo-Casares, Sebastián San Martín, Víctor Carriel

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

David Sánchez-Porras *Department of Histology (Tissue Engineering Group), Faculty of Medicine, University of Granada, and Instituto de Investigación Biosanitaria, Ibs.GRANADA, Granada, Spain.
Juan Varas *Centro de Investigaciones Biomédicas, Escuela de Medicina, Facultad de Medicina, Universidad de Valparaíso, Valparaíso, Chile.
Carlos Godoy-GuzmánCentro de Investigación Biomédica y Aplicada (CIBAP), Escuela de Medicina, Universidad de Santiago de Chile, (USACH), Santiago, Chile.
Fabiola Bermejo-CasaresDepartment of Histology (Tissue Engineering Group), Faculty of Medicine, University of Granada, and Instituto de Investigación Biosanitaria, Ibs.GRANADA, Granada, Spain.
Sebastián San MartínCentro de Investigaciones Biomédicas, Escuela de Medicina, Facultad de Medicina, Universidad de Valparaíso, Valparaíso, Chile.
Víctor CarrielDepartment of Histology (Tissue Engineering Group), Faculty of Medicine, University of Granada, and Instituto de Investigación Biosanitaria, Ibs.GRANADA, Granada, Spain. vcarriel@ugr.es.
Instituto de Investigación Biosanitaria de Granada · ESUniversity of Valparaíso · CLUniversidad de Santiago de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteoglycans (PGs) are non-fibrillar extracellular matrix (ECM) molecules composed by a protein core and glycosaminoglycan (GAG) chains. These molecules are present in all tissues playing essential structural, biomechanical, and biological roles. In addition, PGs can regulate cell behavior due to their versatility and ability to interact with other ECM molecules, growth factors, and cells. The distribution of PGs can be evaluated by histochemical and immunohistochemical methods. Histochemical methods aimed to provide a useful overview of the presence and distribution pattern of certain groups of PGs. In contrast, immunohistochemical procedures aimed the identification of highly specific target molecules. In this chapter we described Alcian Blue, Safranin O, and Toluidine Blue histochemical methods for the screening of PGs in tissue sections. Finally, we describe the immunohistochemical procedures for specific identification of PGs (decorin, biglycan, and versican) in formaldehyde-fixed and paraffin-embedded tissues.

Indexed as

Extracellular Matrix ProteinsVersicansAlcian BlueBiglycanChondroitin Sulfate ProteoglycansDecorinFormaldehydeGlycosaminoglycansTolonium ChlorideAlcian BlueBiglycanChondroitin Sulfate ProteoglycansDecorinExtracellular Matrix ProteinsFormaldehydeGlycosaminoglycansTolonium ChlorideVersicansCarbohydrate histochemistryExtracellular matrixFormaldehyde-fixed tissuesHistochemistryImmunohistochemistryProteoglycans

Identifiers

PMID36152244
OpenAlexW4297250254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.